Michael Joffe ST6 Haematology SpR

Size: px
Start display at page:

Download "Michael Joffe ST6 Haematology SpR"

Transcription

1 Michael Joffe ST6 Haematology SpR

2 Mrs SB 71 year old female on AMU Telephone referral to haematology by medicine with Hb 102 MCV 89, normal B12, Folate, Ferritin. PMH DM General decline over several weeks Dysuria AKI cr 326 egfr 8 Nausea Shoulder pain

3 History Was well a month ago Reduced appetite 3 UTIs in past 6 months Shoulder pain has come on over about 6 weeks No fevers or night sweats

4 Blood film Myeloma screen Urine dip US KUB Virology Shoulder x-ray

5 Serum electrophoresis IgA 0.5 ( ) IgG 6.1 ( ) IgM 0.53 ( ) 1.5g IgG paraprotein detected Blood film mild rouleaux only

6

7 Serum Free Light Chain assay Bence Jones Protein

8 20% MM is light chain myeloma Cant do a screen with Serum electrophoresis alone. NICE and IMWG guidance to do both

9 Serum Free Light Chain assay Bence Jones Protein ACR PCR remember to look back. Common test often performed by GPs

10 09/06/14 30/09/13 21/08/12 Urine PCR Urine ACR Urine 5.51 g/l 6.32 g/l 3.62 g/l Protein Urine 78 mg/l 81 mg/l albumin Hb 89 g/l Not done Not done Serum Creatinine

11 Serum electrophoresis IgA 0.5 ( ) IgG 6.4 ( ) IgM 0.58 ( g/L paraprotein detected Serum free light chains Kappa ( ) Lambda 7.1 ( ) K:L ( )

12 Unexplained anaemia esp NCNC Unexplained macrocytosis Abnormal/discrepant Urine PCR and ACR Unexplained proteinuria esp in diabetics i.e. high PCR but low ACR Non resolving bone pain esp backache Bone pain needing morphine based analgesia Vertebral fractures. Pathological fractures Unexplained renal impairment Unexplained high calcium Nephrotic syndrome Unexplained cardiac failure All neuropathies, carpel tunnel syndrome Recurrent bacterial infections Incidental persistent elevated inflammatory markers

13 MGUS Myeloma Plasmacytoma Waldenstroms Macroglobulinaemia Low grade NHL Amyloid

14

15

16 Calcium Renal Failure Anaemia Bone Lesions

17 Minnesota population study, MGUS was present in 1 2% of people in their sixth decade, 2 4% in their seventh decade, rising to 4 5% in their eighth decade (Kyle et al, 2006) Can be IgG, A or M, or light chain Not a cancer. But has a risk of progression.

18 Patient forgot to mention headaches for past week. Unusual for her

19 Neurology Renal failure HYPERVISCOSITY Immune complications High plasma viscosity that is unexplained Look for a paraprotein May need plasma exchange

20 83 year old male Admitted to AMU after a fall Urine dip + nitrites FBC shows Hb123 Platelets 121 WCC 29.2

21 WCC 29.2 Neutrophils 19.2 Lymphocytes 1.8 Monocytes 0.8 Eosinophils 0.9? Infection or CML

22 WCC 29.2 Neutrophils 14.4 Lymphocytes 3.6 Monocytes 8.6 Eosinophils 0.2 CMML likely Persistnent inflammation causes monocytosis

23 WCC 29.2 Neutrophils 4.7 Lymphocytes 24.1 Monocytes 0.4 Eosinophils 0.2 Low grade lymphoproliferative disorder CLL most likely. Remember lymphocyte count can rise with infection too.

24 WCC 29.2 Neutrophils 8.7 Lymphocytes 2.1 Monocytes 0.4 Eosinophils 15.2

25 WCC 29.2 Neutrophils 0.23 Lymphocytes 1.3 Monocytes 0.4 Eosinophils 0.2? AML Needs urgent haematology input

26 CML CMML

27 CML MPD - Proliferation of myeloid cell lines CMML MPD/MDS with proliferation of monocytic cell line. It is characterised by the presence of monocytes. NOT INTERCHANGEABLE

28 Different pathology Different treatment approach Tki vs supportive/cytoreductive treatment

29 CML CMML PV ET SM Eosinophilia associated with PDGFRA

30 72 year old male, Caucasian 3 weeks cough yellow sputum improving Hb 104 platelets 162 neutrophils 1.1 PMH Diabetes and HTN

31 Medications - Phenytoin, Bisoprolol, Gliclazide. Had Amoxicillin 2 weeks ago for LRTI from GP. No FH Never smoked. 4 units alcohol/week

32 Differential? Possibilities

33 Infection related Drug induced Immune Nutritional Bone marrow disease Familial

34 REPEAT Review the drug chart Film B12, folate, ferritin Serum electrophoresis Autoimmune (ANA, RF) Viral infection Coagulation screening tests Bone Marrow aspirate and trephine

35 Algorithm for the evaluation and treatment of adult patients with neutropenia. Christopher Gibson, and Nancy Berliner Blood 2014;124: by American Society of Hematology

36

37

38

39

40 Serum electrophoresis normal B12/folate normal film essentially normal Sputum mycoplasma

41 Infection +/- antibiotic induced neutropenia Repeat neutrophil count normal 1-2 weeks later If it doesn t improve after 4 weeks or continues to get worse Haematology needed.

42

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group GP Referral Guidelines for South Wales Cancer Network Document Control Sheet Organisation South Wales Cancer Network Specialty/Project Haematological Site Specific Group Document Title GP Referral Guidelines

More information

Anaemias and other Pesky Haematology Questions

Anaemias and other Pesky Haematology Questions Anaemias and other Pesky Haematology Questions 3 main topics How do I work out an anaemia.. That oh too common paraprotein patient. Those mildly raised lymphocyte count GP discussed patient with me over

More information

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance)

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance) Southern Derbyshire Shared Care Pathology Guidelines MGUS (Monoclonal Gammopathy of Undetermined Significance) Purpose of guideline This guideline provides information about the risk stratification of

More information

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma Fifth stage Lec-14 د.خالد نافع Medicine 24/4/2016 Multiple Myeloma Plasma cell myeloma Variants Non - secretory myeloma Indolent myeloma Smouldering myeloma Plasma cell leukaemia Plasmacytoma - Solitary

More information

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + Disclosures Advisory Boards: AMGEN, Lundbeck, NOVARTIS + Subtypes of Plasma Cell Disorders Increased Plasma

More information

Candidates must answer ALL questions

Candidates must answer ALL questions Time allowed: Three hours. Part 1 examination Haematology: First paper Tuesday 22 March 2016 Candidates must answer ALL questions Question 1: General Haematology A 16 year old non-european is referred

More information

Common Haematological Problems in Primary Care

Common Haematological Problems in Primary Care 23 rd March 2019 GP Hot Topics In Primary Care Common Haematological Problems in Primary Care Dr Samar Kulkarni Consultant Haematologist-Oncologist and The Christie Private Care Manchester, UK. Haematology?

More information

Hematology Case Conference 8/5/03

Hematology Case Conference 8/5/03 Hematology Case Conference 8/5/03 Bone Marrow Case Patient: Emmxxx Lylexxx 74 year old AA female S/P craniotomy for SDH. Pt has Hx of HTN, DM, Crohn s disease, (R) nephrectomy. Bone marrow for abnormal

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

Western Health Specialist Clinics Access & Referral Guidelines

Western Health Specialist Clinics Access & Referral Guidelines Haematology Specialist Clinics at Western Health: Western Health runs MBS funded Specialist Clinics on a Wednesday and Thursday afternoon at its Sunshine Hospital site for patients who require assessment

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology 1 Version control: There are two controlled versions of this document, one for GSTT and one for KCH. While

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

Haematology dilemma s to refer or not to refer?

Haematology dilemma s to refer or not to refer? Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer

More information

Interpreting Blood Tests Part 1. Dr Andrew Smith

Interpreting Blood Tests Part 1. Dr Andrew Smith Interpreting Blood Tests Part 1 Dr Andrew Smith Outline Part 1 (This Week) Introduction Which Tube!?! FBCs U+Es Part 2 (Next Week): More Electrolytes LFTs Clotting Extras Introduction Bloods are a core

More information

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology For two week wait pathway, please continue to use existing documentation/pathways. Telephone advice and guidance

More information

REGISTRATION FORM 1 / 2

REGISTRATION FORM 1 / 2 IDENTIFICATION AND BASELINE DATA REGISTRATION FORM 1 / 2 M Patient s initials: Sequential case N : SEX : F Date of birth: Place of birth I I Centre I I Address I I Telephone number I I Actual profession

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Blood Cancers in the Community

Blood Cancers in the Community Over to you, mate Blood Cancers in the Community National Rural Health Conference NZ Rural General Practice Network April 7, 2018 Brian Grainger Haematology Registrar Auckland Acknowledgements Dr James

More information

GP CME. James Liang Consultant Haematologist. Created by: Date:

GP CME. James Liang Consultant Haematologist. Created by: Date: GP CME James Liang Consultant Haematologist Date: Created by: Scenario 52 year old European male Fit and well Brother recently diagnosed with diabetes PMHx Nil Social Hx Ex-smoker stopped 5 years ago (20

More information

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist Borderline cytopenias Dr Taku Sugai Consultant Haematologist Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias Neutropenia ANC of more than

More information

Haematology for GP's

Haematology for GP's Haematology for GP's Dr Christina Zouvelou Consultant Haematologist SOUTHEND UNIVERSITY HOSPITALS NHS FT SPIRE WELLESLEY HOSPITAL Time to Learn, 03/07/2018 Anaemia Careful history (duration, symptoms,

More information

Multiple Myeloma 101: Understanding Your Labs

Multiple Myeloma 101: Understanding Your Labs Multiple Myeloma 101: Understanding Your Labs Tim Wassenaar MD MS Hematologist, Director of Clinical Trials UW Cancer Center at ProHealth Care None Disclosures Outline Define hematopoiesis WBCs, RBCs,

More information

Multiple myeloma: from diagnosis to treatment

Multiple myeloma: from diagnosis to treatment Diagnostic challenges Renee Eslick Dipti Talaulikar Multiple : from diagnosis to treatment Background Multiple is characterised by the proliferation of malignant plasma cells within the bone marrow, which

More information

The ABCs of Waldenström s Macroglobulinemia (WM)

The ABCs of Waldenström s Macroglobulinemia (WM) The ABCs of Waldenström s Macroglobulinemia (WM) Jeffrey V. Matous MD Colorado Blood Cancer Institute IWMF Ed Forum May 2017 Objectives Describe the roots underneath WM Review incidence, possible risk

More information

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Cytopaenias in HIV Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Introduction Cytopaenias in HIV are common Anaemias multifactorial causes Thrombocytopaenias may be the first

More information

Complete Blood Count in Primary Care

Complete Blood Count in Primary Care QUIZ FEEDBACK Complete Blood Count in Primary Care bpac nz better medicine GP Review Panel: Dr Janine Bailey, Motueka Dr Susie Lawless, Dunedin Dr Randall Sturm, Auckland Dr Neil Whittaker, Nelson Specialist

More information

Adult Acute leukemia. Matthew Seftel. August

Adult Acute leukemia. Matthew Seftel. August Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications

More information

This is a controlled document and therefore must not be changed

This is a controlled document and therefore must not be changed AZACITIDINE NICE TA218 Treatment of adults not eligible for haematopoietic stem cell transplantation who have: Intermediate-2 and high-risk MDS according to the International Prognostic Scoring System

More information

Laboratory Examination

Laboratory Examination Todd Zimmerman, M.D. 64 year old African American male presents to establish care with PCG. Meds: Norvasc 5 mg daily PMHx: HTN x 20 years, poorly controlled SHx: No tobacco, illicit; rare EtOH ROS: Negative

More information

Professor Suetonia Palmer

Professor Suetonia Palmer Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

Serum free light chain (SFLC) assays. Dr Sarah Sasson SydPath Registrar

Serum free light chain (SFLC) assays. Dr Sarah Sasson SydPath Registrar Serum free light chain (SFLC) assays Dr Sarah Sasson SydPath Registrar Introduction to SFLC Plasma cell dyscrasias such as monoclonal gammopathy of uncertain significance (MGUS) smouldering/asymptomatic

More information

Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT

Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT The Kidney in Multiple Myeloma Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT Normal Cell Plasma cells produce antibodies that bind to antigens,

More information

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA Trish Hyland, Medical Scientist, Department of Haematology, Cork University Hospital

More information

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks.

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks. Part 1 examination Haematology: First paper Tuesday 20 March 2018 Candidates must answer all questions. Each question is worth a total of 25 marks. Time allowed: 3 hours Question 1: General Haematology

More information

Azathioprine Shared Care Guideline for GPs

Azathioprine Shared Care Guideline for GPs Indication: Azathioprine Shared Care Guideline for GPs Active rheumatoid arthritis and other types of inflammatory arthritis, systemic lupus erythematosus, dermatomyositis and polymyositis, vasculitis

More information

Plasma cell myeloma (multiple myeloma)

Plasma cell myeloma (multiple myeloma) Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells

More information

Mr Matthew Eby. Dr Humphrey Pullon

Mr Matthew Eby. Dr Humphrey Pullon Dr Humphrey Pullon Haematologist Hamilton Mr Matthew Eby Senior Support Services Coordinator Leukaemia & Blood Cancer Foundation New Zealand Hamilton 16:30-17:25 WS #64: Managing Haemopoetic Disease in

More information

Criteria for Disease Assessment Joan Bladé

Criteria for Disease Assessment Joan Bladé Criteria for Disease Assessment Joan Bladé Unidad de Amiloidosis y Mieloma Servicio de Hematología Hospital Clínic de Barcelona COMy Meeting, París, May 4th, 2018 Response Evaluation EBMT, 1998 - CR and

More information

UH Bristol Haematology Referral Guidelines for Primary Care

UH Bristol Haematology Referral Guidelines for Primary Care UH Bristol Haematology Referral Guidelines for Primary Care INTRODUCTION University Hospital Bristol (UHBristol) hosts a regional adult haematology clinical service and offers diagnosis and on-going management

More information

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities

More information

Importancia del laboratorio en el seguimiento clínico de pacientes con mieloma múltiple

Importancia del laboratorio en el seguimiento clínico de pacientes con mieloma múltiple Importancia del laboratorio en el seguimiento clínico de pacientes con mieloma múltiple Joan Bladé Unidad de Amiloidosis y Mieloma Servicio de Hematología Hospital Clínic de Barcelona Málaga, 16 de noviembre

More information

Multiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Multiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia Multiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia Salem H. Khalil, MB, BS; M. Andrew Padmos, BA(Hons), MD, FRCP(C); Peter Ernst MD, PhD;

More information

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Leukemias Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Introduction Leukaemias are malignant disorders of the haematopoietic stem cell compartment,

More information

Smoldering Multiple Myeloma. A Case Study

Smoldering Multiple Myeloma. A Case Study Smoldering Multiple Myeloma A Case Study Case Presentation 53-Year-Old Male Patient presented for a routine exam No prior history of disease or family history of fhematologic disorders d or malignancies,

More information

Guideline for the Management of Patients with Myeloma

Guideline for the Management of Patients with Myeloma Version History Guideline for the Management of Patients with Myeloma Version Summary of change Date Issued 1.0 Endorsed by the Governance Committee 11.05.06 1.1 Following review by Guy Pratt 19.02.08

More information

Multiple myeloma Biological & Clinical Aspects Isabelle Vande Broek, MD, PhD

Multiple myeloma Biological & Clinical Aspects Isabelle Vande Broek, MD, PhD Multiple myeloma Biological & Clinical Aspects Isabelle Vande Broek, MD, PhD Department of Oncology & Hematology AZ Nikolaas Iridium Kanker Netwerk Introduction Multiple myeloma = Kahler s disease Dr.

More information

H(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute

H(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute H(a)ematuria FX Keeley Consultant Urologist Bristol Urological Institute From Philadelphia to Bristol, England Southmead Hospital, 1916 Southmead Hospital, 2013 Southmead Hospital, 2014 H(a)ematuria Blood

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

Management Update: Multiple Myeloma. Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College

Management Update: Multiple Myeloma. Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College Management Update: Multiple Myeloma Presented by Prof. Dr. Khan Abul Kalam Azad Professor of Medicine Dhaka Medical College Introduction Multiple myeloma - clonal plasma cell neoplasm Monoclonal antibody

More information

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL RESPONSE ASSESSMENT MYELOMA CHAPTER 11C REVISED: SEPTEMBER 2016

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL RESPONSE ASSESSMENT MYELOMA CHAPTER 11C REVISED: SEPTEMBER 2016 MYELOMA Quantitative Markers-Myeloma Assessment Quantitative markers are biochemicals that are recorded in tests on body fluids such as serum and urine. Applicable Disease Sites The myeloma disease site

More information

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology

More information

Laboratory diagnosis of plasma proteins and plasma enzymes

Laboratory diagnosis of plasma proteins and plasma enzymes Laboratory diagnosis of plasma proteins and plasma enzymes Functions of plasma proteins Function: transport humoral immunity enzymes protease inhibitors maintenance of oncotic pressure buffering Example:

More information

Myeloma. A guide for patients and families leukaemia.org.au

Myeloma. A guide for patients and families leukaemia.org.au Myeloma A guide for patients and families 1800 620 420 leukaemia.org.au Contents Acknowledgments 4 Introduction 5 The Leukaemia Foundation 6 Blood cancers 10 What is myeloma? 16 Who gets myeloma? 20 How

More information

Clinical Utility. Clinical Utility of the Automated IG-Count Xavier Troussard

Clinical Utility. Clinical Utility of the Automated IG-Count Xavier Troussard 5. Clinical Utility Clinical Utility of the Automated IG-Count Xavier Troussard Introduction Quantitative analysis of immature granulocytes (IG) is useful for the optimal clinical and biological management

More information

Problem Based Learning

Problem Based Learning Problem Based Learning 2 Dania Qarqash&OmaymaHassanin Enas Ajarma Dr.Hikmat Abdel-Razeq Clinical hematology is divided into four subjects : 1- Benign hematology Anemia Benign WBC disorders Bone marrow

More information

Panobinostat, Bortezomib and Dexamethasone

Panobinostat, Bortezomib and Dexamethasone Panobinostat, Bortezomib and Dexamethasone Indication Treatment of relapsed/refractory multiple myeloma in patients who have received at least 2 prior regimens, including bortezomib and an immunomodulatory

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia Blood Malignancies-II Prof. Dr. Herman Hariman, a Ph.D, SpPK (KH). Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. of Clinical Pathology, School of Medicine, University of North Sumatra WHO classification

More information

TESTS AND INVESTIGATIONS FOR MULTIPLE MYELOMA A guide for patients and caregivers

TESTS AND INVESTIGATIONS FOR MULTIPLE MYELOMA A guide for patients and caregivers TESTS AND INVESTIGATIONS FOR MULTIPLE MYELOMA A guide for patients and caregivers Developed by the Myeloma Special Practice Network (M-SPN) of the Haematology Society of Australia and New Zealand (HSANZ)

More information

The Paraprotein. Evaluating Paraproteinemia. Conditions Associated with PP. Paraprotein Structure

The Paraprotein. Evaluating Paraproteinemia. Conditions Associated with PP. Paraprotein Structure Evaluating Paraproteinemia Jeffrey Wolf, MD, Director Thomas Martin, MD, Associate Director Myeloma Institute University of California, San Francisco The Paraprotein An abnormal immunoglobulin or part

More information

Evaluating Paraproteinemia

Evaluating Paraproteinemia Evaluating Paraproteinemia Jeffrey Wolf, MD, Director Thomas Martin, MD, Associate Director Myeloma Institute University of California, San Francisco The Paraprotein An abnormal immunoglobulin or part

More information

HYDROXYCARBAMIDE for Haematological conditions (Adults)

HYDROXYCARBAMIDE for Haematological conditions (Adults) Shared Care Guideline DRUG: Introduction: Contraindications & Warnings: HYDROXYCARBAMIDE for Haematological conditions (Adults) Indication: Hydroxycarbamide is an established treatment in haematological

More information

SHARED CARE PRESCRIBING GUIDELINE

SHARED CARE PRESCRIBING GUIDELINE WORKING IN PARTNERSHIP East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG, Surrey Heath CCG, North East Hampshire & Farnham CCG, Crawley CCG, Horsham & Mid-Sussex CCG SHARED

More information

CASE 3 AN UNUSUAL CASE OF NEPHROTIC SYNDROME

CASE 3 AN UNUSUAL CASE OF NEPHROTIC SYNDROME CASE 3 AN UNUSUAL CASE OF NEPHROTIC SYNDROME Dr Seethalekshmy N.V., Dr.Annie Jojo, Dr Hiran K.R., Amrita institute of Medical Sciences, Kochi, Kerala Case history 34 year old gentleman Nephrotic range

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

TREATMENT INTENT Disease modification- see European LeukemiaNet (ELN) 2013 guidelines for treatment goals.

TREATMENT INTENT Disease modification- see European LeukemiaNet (ELN) 2013 guidelines for treatment goals. BOSUTINIB INDICATION Licensed / NICE TA401 (BLUETEQ required) The treatment of adult patients with chronic, accelerated and blast phase Philadelphia chromosome positive chronic myeloid leukaemia (Ph+ CML)

More information

Plasma proteins Quantitatively, proteins are the most important part of the soluble components of the blood plasma.

Plasma proteins Quantitatively, proteins are the most important part of the soluble components of the blood plasma. Plasma proteins 42 Plasma proteins Quantitatively, proteins are the most important part of the soluble components of the blood plasma. concentrations of between 60 and 80 g L 1, they constitute approximately

More information

It is also an option for those with Ph+ve CML who initially present in accelerated phase or with blast crisis 1.

It is also an option for those with Ph+ve CML who initially present in accelerated phase or with blast crisis 1. Imatinib (Glivec ) Indications 1 Imatinib is recommended as first line treatment for people with Philadelphia chromosome positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase 1. It is also an

More information

Leukocytosis. dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University

Leukocytosis. dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University Leukocytosis dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University My first day at work in 1997 3y with fever, cough Is this bronchitis, pneumonia, pharyngitis, sinusitis, else? Is this

More information

GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust

GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust GP Education Haematology laboratory abnormalities- when to refer? Priyanka Mehta Consultant Haematologist UH Bristol NHS Trust Topics for discussion Abnormal FBCs Lymphocytosis high and low platelets cytopenias

More information

Multiple Myeloma Early Detection, Diagnosis, and Staging

Multiple Myeloma Early Detection, Diagnosis, and Staging Multiple Myeloma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be

More information

Part 1 examination. Haematology: First paper. Tuesday 25 September 2018

Part 1 examination. Haematology: First paper. Tuesday 25 September 2018 Part 1 examination Haematology: First paper Tuesday 25 September 2018 Candidates must answer all questions. Each question is worth a total of 25 marks. Time allowed: 3 hours 1. Haemato-oncology. A 22 year

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

Jo Abraham MD Division of Nephrology University of Utah

Jo Abraham MD Division of Nephrology University of Utah Jo Abraham MD Division of Nephrology University of Utah 68 year old male presented 3 weeks ago with a 3 month history of increasing fatigue He reported a 1 week history of increasing dyspnea with a productive

More information

Monoclonal Gammopathy with Systemic Amyloidosis: An Evaluation of Diagnostic Elements

Monoclonal Gammopathy with Systemic Amyloidosis: An Evaluation of Diagnostic Elements : 51-55 Monoclonal Gammopathy with Systemic Amyloidosis: An Evaluation of Diagnostic Elements 1 C. T Subashini*, 1 E. George & 2 U Nor Aini 1 Department of Pathology, Faculty of Medicine and Health Sciences,

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

CKD & HT. Anne-Marie Angus

CKD & HT. Anne-Marie Angus CKD & HT Anne-Marie Angus Hypertension definitions Persisting BP >140/90 and HBPM >135/85 Stage 1 >140/90 (HBPM >135/85) Stage 2 >160/100 (HBPM >150/90) Severe >180/100 White coat HT Why treat? A major

More information

Instructions for Plasma Cell Disorders (PCD) Post-HCT Data (Form 2116 Revision 3)

Instructions for Plasma Cell Disorders (PCD) Post-HCT Data (Form 2116 Revision 3) (Form 2116 Revision 3) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Plasma Cell Disorders (PCD) Post-HCT Data Form. E-mail comments regarding the

More information

Early diagnosis saves lives #SpotLeukaemia

Early diagnosis saves lives #SpotLeukaemia Early diagnosis saves lives #SpotLeukaemia Leukaemia... is a blood cancer affects people of all ages Leukaemia symptoms are hard to spot, as they are similar to the symptoms of common, unrelated conditions.

More information

Bronchiectasis in Adults - Suspected

Bronchiectasis in Adults - Suspected Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

FLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018

FLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 FLOW CYTOMETRY PRINCIPLES AND PRACTICE Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 Aims and Objectives Principles of flow cytometry Preparation Steps involved

More information

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial

More information

CKD and risk management : NICE guideline

CKD and risk management : NICE guideline CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of

More information

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018 GP refresher course Anaemia Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018 None Declarations WHO thresholds Hb (g/l) Children 0.5 5 yrs 110 Children 5 12 yrs 115 Teens

More information

Case #1. Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute

Case #1. Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute Case #1 Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute Patient History Part I 76 year-old man 1997 diagnosed with MGUS (biclonal) during evaluation of (self-limited) anemia.

More information

4.05 Protocol name: Alemtuzumab (MabCampath ), intravenous

4.05 Protocol name: Alemtuzumab (MabCampath ), intravenous 4.05 Protocol name: (MabCampath ), intravenous Indication Treatment of CLL refractory to fludarabine (either primary i.e. 17p deletion, or secondary i.e. following previous fludarabine treatment), without

More information

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal Gammopathies and the Kidney Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal gammopathy of renal significance (MGRS) Biopsies at OSU (n=475) between 2007 and 2016 AL or AH

More information

WHAT IS YOUR DIAGNOSIS?

WHAT IS YOUR DIAGNOSIS? WHAT IS YOUR DIAGNOSIS? A 1.5 year, male neuter, domestic shorthair cat was presented to the R(D)SVS Internal Medicine Service with a three month history of pica (ingestion of cat litter and licking concrete)

More information

NCCP Chemotherapy Regimen

NCCP Chemotherapy Regimen INDICATIONS FOR USE: Azacitidine i INDICATION ICD10 Regimen Code *Reimbursement Status Intermediate-1 and low risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System

More information

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH Contents: Page No. 1. Overview 2 2. Admission 3 3. Admission Checklist 5 4. Inpatient management during chemotherapy 6 5. Inpatient

More information

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type

More information

Osteosclerotic Myeloma (POEMS Syndrome)

Osteosclerotic Myeloma (POEMS Syndrome) Osteosclerotic Myeloma (POEMS Syndrome) Osteosclerotic Myeloma (POEMS Syndrome) Synonyms Crow-Fukase syndrome Multicentric Castleman disease Takatsuki syndrome Acronym coined by Bardwick POEMS Scheinker,

More information